These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30717814)

  • 1. Striatal amyloid is associated with tauopathy and memory decline in familial Alzheimer's disease.
    Hanseeuw BJ; Lopera F; Sperling RA; Norton DJ; Guzman-Velez E; Baena A; Pardilla-Delgado E; Schultz AP; Gatchel J; Jin D; Chen K; Reiman EM; Johnson KA; Quiroz YT
    Alzheimers Res Ther; 2019 Feb; 11(1):17. PubMed ID: 30717814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.
    Quiroz YT; Sperling RA; Norton DJ; Baena A; Arboleda-Velasquez JF; Cosio D; Schultz A; Lapoint M; Guzman-Velez E; Miller JB; Kim LA; Chen K; Tariot PN; Lopera F; Reiman EM; Johnson KA
    JAMA Neurol; 2018 May; 75(5):548-556. PubMed ID: 29435558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees.
    Klunk WE; Price JC; Mathis CA; Tsopelas ND; Lopresti BJ; Ziolko SK; Bi W; Hoge JA; Cohen AD; Ikonomovic MD; Saxton JA; Snitz BE; Pollen DA; Moonis M; Lippa CF; Swearer JM; Johnson KA; Rentz DM; Fischman AJ; Aizenstein HJ; DeKosky ST
    J Neurosci; 2007 Jun; 27(23):6174-84. PubMed ID: 17553989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET evidence of preclinical cerebellar amyloid plaque deposition in autosomal dominant Alzheimer's disease-causing Presenilin-1 E280A mutation carriers.
    Ghisays V; Lopera F; Goradia DD; Protas HD; Malek-Ahmadi MH; Chen Y; Devadas V; Luo J; Lee W; Baena A; Bocanegra Y; Guzmán-Vélez E; Pardilla-Delgado E; Vila-Castelar C; Fox-Fuller JT; Hu N; Clayton D; Thomas RG; Alvarez S; Espinosa A; Acosta-Baena N; Giraldo MM; Rios-Romenets S; Langbaum JB; Chen K; Su Y; Tariot PN; Quiroz YT; Reiman EM;
    Neuroimage Clin; 2021; 31():102749. PubMed ID: 34252876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal amyloid and tau accumulation in autosomal dominant Alzheimer's disease: findings from the Colombia-Boston (COLBOS) biomarker study.
    Sanchez JS; Hanseeuw BJ; Lopera F; Sperling RA; Baena A; Bocanegra Y; Aguillon D; Guzmán-Vélez E; Pardilla-Delgado E; Ramirez-Gomez L; Vila-Castelar C; Martinez JE; Fox-Fuller JT; Ramos C; Ochoa-Escudero M; Alvarez S; Jacobs HIL; Schultz AP; Gatchel JR; Becker JA; Katz SR; Mayblyum DV; Price JC; Reiman EM; Johnson KA; Quiroz YT
    Alzheimers Res Ther; 2021 Jan; 13(1):27. PubMed ID: 33451357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High striatal amyloid beta-peptide deposition across different autosomal Alzheimer disease mutation types.
    Villemagne VL; Ataka S; Mizuno T; Brooks WS; Wada Y; Kondo M; Jones G; Watanabe Y; Mulligan R; Nakagawa M; Miki T; Shimada H; O'Keefe GJ; Masters CL; Mori H; Rowe CC
    Arch Neurol; 2009 Dec; 66(12):1537-44. PubMed ID: 20008660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden.
    Buckley RF; Hanseeuw B; Schultz AP; Vannini P; Aghjayan SL; Properzi MJ; Jackson JD; Mormino EC; Rentz DM; Sperling RA; Johnson KA; Amariglio RE
    JAMA Neurol; 2017 Dec; 74(12):1455-1463. PubMed ID: 28973551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Visual Memory and
    Bocanegra Y; Fox-Fuller JT; Baena A; Guzmán-Vélez E; Vila-Castelar C; Martínez J; Torrico-Teave H; Lopera F; Quiroz YT
    J Int Neuropsychol Soc; 2021 Jan; 27(1):47-55. PubMed ID: 32762790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Entorhinal cortex tau, amyloid-β, cortical thickness and memory performance in non-demented subjects.
    Knopman DS; Lundt ES; Therneau TM; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Machulda MM; Boeve BF; Jones DT; Graff-Radford J; Albertson SM; Schwarz CG; Petersen RC; Jack CR
    Brain; 2019 Apr; 142(4):1148-1160. PubMed ID: 30759182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The correlation between striatal and cortical binding ratio of
    Sauerbeck J; Ishii K; Hosokawa C; Kaida H; Scheiwein FT; Hanaoka K; Rominger A; Brendel M; Bartenstein P; Murakami T
    Ann Nucl Med; 2018 Jul; 32(6):398-403. PubMed ID: 29730823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease.
    Rodriguez-Vieitez E; Saint-Aubert L; Carter SF; Almkvist O; Farid K; Schöll M; Chiotis K; Thordardottir S; Graff C; Wall A; Långström B; Nordberg A
    Brain; 2016 Mar; 139(Pt 3):922-36. PubMed ID: 26813969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing amyloid-β plaque burden with antemortem PiB PET in autosomal dominant and late-onset Alzheimer disease.
    Chen CD; Joseph-Mathurin N; Sinha N; Zhou A; Li Y; Friedrichsen K; McCullough A; Franklin EE; Hornbeck R; Gordon B; Sharma V; Cruchaga C; Goate A; Karch C; McDade E; Xiong C; Bateman RJ; Ghetti B; Ringman JM; Chhatwal J; Masters CL; McLean C; Lashley T; Su Y; Koeppe R; Jack C; Klunk WE; Morris JC; Perrin RJ; Cairns NJ; Benzinger TLS
    Acta Neuropathol; 2021 Oct; 142(4):689-706. PubMed ID: 34319442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study.
    Fleisher AS; Chen K; Quiroz YT; Jakimovich LJ; Gomez MG; Langois CM; Langbaum JB; Ayutyanont N; Roontiva A; Thiyyagura P; Lee W; Mo H; Lopez L; Moreno S; Acosta-Baena N; Giraldo M; Garcia G; Reiman RA; Huentelman MJ; Kosik KS; Tariot PN; Lopera F; Reiman EM
    Lancet Neurol; 2012 Dec; 11(12):1057-65. PubMed ID: 23137949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational study.
    Chhatwal JP; Schultz SA; McDade E; Schultz AP; Liu L; Hanseeuw BJ; Joseph-Mathurin N; Feldman R; Fitzpatrick CD; Sparks KP; Levin J; Berman SB; Renton AE; Esposito BT; Fernandez MV; Sung YJ; Lee JH; Klunk WE; Hofmann A; Noble JM; Graff-Radford N; Mori H; Salloway SM; Masters CL; Martins R; Karch CM; Xiong C; Cruchaga C; Perrin RJ; Gordon BA; Benzinger TLS; Fox NC; Schofield PR; Fagan AM; Goate AM; Morris JC; Bateman RJ; Johnson KA; Sperling RA;
    Lancet Neurol; 2022 Feb; 21(2):140-152. PubMed ID: 35065037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BDNF Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer's disease.
    Lim YY; Hassenstab J; Cruchaga C; Goate A; Fagan AM; Benzinger TL; Maruff P; Snyder PJ; Masters CL; Allegri R; Chhatwal J; Farlow MR; Graff-Radford NR; Laske C; Levin J; McDade E; Ringman JM; Rossor M; Salloway S; Schofield PR; Holtzman DM; Morris JC; Bateman RJ;
    Brain; 2016 Oct; 139(Pt 10):2766-2777. PubMed ID: 27521573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorodeoxyglucose metabolism associated with tau-amyloid interaction predicts memory decline.
    Hanseeuw BJ; Betensky RA; Schultz AP; Papp KV; Mormino EC; Sepulcre J; Bark JS; Cosio DM; LaPoint M; Chhatwal JP; Rentz DM; Sperling RA; Johnson KA
    Ann Neurol; 2017 Apr; 81(4):583-596. PubMed ID: 28253546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Emerging β-Amyloid and Tau Pathology With Early Cognitive Changes in Clinically Normal Older Adults.
    Farrell ME; Papp KV; Buckley RF; Jacobs HIL; Schultz AP; Properzi MJ; Vannini P; Hanseeuw BJ; Rentz DM; Johnson KA; Sperling RA
    Neurology; 2022 Apr; 98(15):e1512-e1524. PubMed ID: 35338074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Latin American Spanish version of the Face-Name Associative Memory Exam is sensitive to cognitive and pathological changes in preclinical autosomal dominant Alzheimer's disease.
    Vila-Castelar C; Muñoz N; Papp KV; Amariglio RE; Baena A; Guzmán-Vélez E; Bocanegra Y; Sanchez JS; Reiman EM; Johnson KA; Sperling RA; Lopera F; Rentz DM; Quiroz YT
    Alzheimers Res Ther; 2020 Sep; 12(1):104. PubMed ID: 32912283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET amyloid ligand [11C]PIB uptake shows predominantly striatal increase in variant Alzheimer's disease.
    Koivunen J; Verkkoniemi A; Aalto S; Paetau A; Ahonen JP; Viitanen M; Någren K; Rokka J; Haaparanta M; Kalimo H; Rinne JO
    Brain; 2008 Jul; 131(Pt 7):1845-53. PubMed ID: 18583368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau accumulation and atrophy predict amyloid independent cognitive decline in aging.
    Fonseca CS; Baker SL; Dobyns L; Janabi M; Jagust WJ; Harrison TM
    Alzheimers Dement; 2024 Apr; 20(4):2526-2537. PubMed ID: 38334195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.